Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells.

Abstract:

:Pim kinases are involved in B-cell development and are overexpressed in B-cell chronic lymphocytic leukemia (CLL). We hypothesized that Pim kinase inhibition would affect B-cell survival. Identified from a screen of imidazo[1,2-b]pyridazine compounds, SGI-1776 inhibits Pim-1, Pim-2, and Pim-3. Treatment of CLL cells with SGI-1776 results in a concentration-dependent induction of apoptosis. To elucidate its mechanism of action, we evaluated the effect of SGI-1776 on Pim kinase function. Unlike in replicating cells, phosphorylation of traditional Pim-1 kinase targets, phospho-Bad (Ser112) and histone H3 (Ser10), and cell-cycle proteins were unaffected by SGI-1776, suggesting an alternative mechanism in CLL. Protein levels of total c-Myc as well as phospho-c-Myc(Ser62), a Pim-1 target site, were decreased after SGI-1776 treatment. Levels of antiapoptotic proteins Bcl-2, Bcl-X(L), XIAP, and proapoptotic Bak and Bax were unchanged; however, a significant reduction in Mcl-1 was observed that was not caused by caspase-mediated cleavage of Mcl-1 protein. The mechanism of decline in Mcl-1 was at the RNA level and was correlated with inhibition of global RNA synthesis. Consistent with a decline in new RNA synthesis, MCL-1 transcript levels were decreased after treatment with SGI-1776. These data suggest that SGI-1776 induces apoptosis in CLL and that the mechanism involves Mcl-1 reduction.

journal_name

Blood

journal_title

Blood

authors

Chen LS,Redkar S,Bearss D,Wierda WG,Gandhi V

doi

10.1182/blood-2009-03-212852

subject

Has Abstract

pub_date

2009-11-05 00:00:00

pages

4150-7

issue

19

eissn

0006-4971

issn

1528-0020

pii

blood-2009-03-212852

journal_volume

114

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Expression of p13MTCP1 is restricted to mature T-cell proliferations with t(X;14) translocations.

    abstract::T-cell prolymphocytic leukemia (T-PLL), a rare form of mature T-cell leukemias, and ataxia telangiectasia clonal proliferation, a related condition occurring in patients suffering from ataxia telangiectasia, have been associated to translocations involving the 14q32.1 or Xq28 regions, where are located the TCL1 and MT...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Madani A,Choukroun V,Soulier J,Cacheux V,Claisse JF,Valensi F,Daliphard S,Cazin B,Levy V,Leblond V,Daniel MT,Sigaux F,Stern MH

    更新日期:1996-03-01 00:00:00

  • Molecular analysis of the structure and expression of the RH locus in individuals with D--, Dc-, and DCw- gene complexes.

    abstract::Rh blood group antigens of the D, C/c, and E/e series are carried by at least three red cell membrane polypeptides encoded by two highly related genes, RHD and RHCE. Homozygous individuals carrying the D--, Dc-, and DCw- gene complexes are characterized by a total or partial lack of expression of the RHCE-encoded anti...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Chérif-Zahar B,Raynal V,D'Ambrosio AM,Cartron JP,Colin Y

    更新日期:1994-12-15 00:00:00

  • Defective delivery of iron to the developing red cell of the Belgrade laboratory rat.

    abstract::Erythroid cell iron and transferrin uptake and release was studied in the anemia of the Belgrade laboratory rat (gene symbol, b), an autosomal recessive trait characterized by hypochromia and hyperferrinemia. When reticulocyte-rich red cells were incubated in vitro with doubly (59Fe, 125I) labeled transferrin, b/b cel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Edwards JA,Sullivan AL,Hoke JE

    更新日期:1980-04-01 00:00:00

  • Regulation of growth differentiation factor 15 expression by intracellular iron.

    abstract::Growth differentiation factor 15 (GDF15) is a divergent member of the transforming growth factor-beta superfamily and has been identified in different contexts as a hypoxia-inducible gene product and as a molecule involved in hepcidin regulation. The biology of iron and oxygen is closely related, and known regulatory ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2008-07-170431

    authors: Lakhal S,Talbot NP,Crosby A,Stoepker C,Townsend AR,Robbins PA,Pugh CW,Ratcliffe PJ,Mole DR

    更新日期:2009-02-12 00:00:00

  • Total lymphoid irradiation and cyclophosphamide as preparation for bone marrow transplantation in severe aplastic anemia.

    abstract::A new combination of total lymphoid irradiation and cyclophosphamide was used prior to bone marrow transplantation in an attempt to achieve decreased rejection rates and graft-versus-host disease. Nine previously transfused patients with severe aplastic anemia received marrow from an HLA-identical, MLC-compatible sibl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ramsay NK,Kim T,Nesbit ME,Krivit W,Coccia PF,Levitt SH,Woods WG,Kersey JH

    更新日期:1980-02-01 00:00:00

  • Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environment.

    abstract::Natural killer (NK) cells play critical roles in protection against hematological malignancies but can acquire a dysfunctional state, which limits antitumor immunity. However, the underlying reasons for this impaired NK cell function remain to be uncovered. We found that NK cells in aggressive B-cell lymphoma underwen...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005602

    authors: Kobayashi T,Lam PY,Jiang H,Bednarska K,Gloury R,Murigneux V,Tay J,Jacquelot N,Li R,Tuong ZK,Leggatt GR,Gandhi MK,Hill MM,Belz GT,Ngo S,Kallies A,Mattarollo SR

    更新日期:2020-12-24 00:00:00

  • Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.

    abstract::B-lymphoid kinase (Blk) is exclusively expressed in B cells and thymocytes. Interestingly, transgenic expression of a constitutively active form of Blk in the T-cell lineage of mice results in the development of T-lymphoid lymphomas. Here, we demonstrate nuclear factor-kappa B (NF-kappaB)-mediated ectopic expression o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-09-181024

    authors: Krejsgaard T,Vetter-Kauczok CS,Woetmann A,Kneitz H,Eriksen KW,Lovato P,Zhang Q,Wasik MA,Geisler C,Ralfkiaer E,Becker JC,Ødum N

    更新日期:2009-06-04 00:00:00

  • Endogenous peroxidase in the nuclear envelope and endoplasmic reticulum of human monocytes in vitro: association with arachidonic acid metabolism.

    abstract::The development of peroxidase (PO) reaction in the nuclear envelope (NE) and endoplasmic reticulum (ER) of monocytes differentiating in vitro and its relationship with arachidonic acid metabolism were studied. The PO, as visualized by the diaminobenzidine (DAB) technique, appeared in the NE and ER of the majority of m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Deimann W,Seitz M,Gemsa D,Fahimi HD

    更新日期:1984-08-01 00:00:00

  • Repression of transcription from the human T-cell leukemia virus type I long terminal repeat and cellular gene promoters by wild-type p53.

    abstract::Human T-cell leukemia virus type-I (HTLV-I), the etiologic agent of adult T-cell leukemia (ATL) transforms human T cells both in vivo and in vitro. However, the long latency period between infection and development of ATL, as well as the small fraction of the infected population that actually develops this disease, su...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mori N,Kashanchi F,Prager D

    更新日期:1997-12-15 00:00:00

  • EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression.

    abstract::Fetal hemoglobin (HbF, α2γ2) induction is a well-validated strategy for sickle cell disease (SCD) treatment. Using a small-molecule screen, we found that UNC0638, a selective inhibitor of EHMT1 and EHMT2 histone methyltransferases, induces γ-globin expression. EHMT1/2 catalyze mono- and dimethylation of lysine 9 on hi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-06-649087

    authors: Renneville A,Van Galen P,Canver MC,McConkey M,Krill-Burger JM,Dorfman DM,Holson EB,Bernstein BE,Orkin SH,Bauer DE,Ebert BL

    更新日期:2015-10-15 00:00:00

  • Potent obatoclax cytotoxicity and activation of triple death mode killing across infant acute lymphoblastic leukemia.

    abstract::Survival in infants younger than 1 year who have acute lymphoblastic leukemia (ALL) is inferior whether MLL is rearranged (R) or germline (G). MLL translocations confer chemotherapy resistance, and infants experience excess complications. We characterized in vitro sensitivity to the pan-antiapoptotic BCL-2 family inhi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-04-425033

    authors: Urtishak KA,Edwards AY,Wang LS,Hudome A,Robinson BW,Barrett JS,Cao K,Cory L,Moore JS,Bantly AD,Yu QC,Chen IM,Atlas SR,Willman CL,Kundu M,Carroll AJ,Heerema NA,Devidas M,Hilden JM,Dreyer ZE,Hunger SP,Reaman GH,

    更新日期:2013-04-04 00:00:00

  • Immunolocalization of the Bcl-2 protein within hematopoietic neoplasms.

    abstract::The Bcl-2 proto-oncogene was discovered at the t(14;18) breakpoint found in most follicular B-cell lymphomas and some diffuse large-cell lymphomas. Bcl-2 is unique among proto-oncogenes, being localized to mitochondria and extending cell survival by blocking programmed cell death. We examined Bcl-2 protein expression ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Zutter M,Hockenbery D,Silverman GA,Korsmeyer SJ

    更新日期:1991-08-15 00:00:00

  • Combined syngeneic bone marrow transplantation and immunotherapy of a murine B-cell lymphoma: active immunization with tumor-derived idiotypic immunoglobulin.

    abstract::Recurrence of the underlying malignancy remains a major cause of treatment failure after autologous bone marrow transplantation (BMT) for patients with lymphoma. In this regard, we have developed an immunotherapeutic approach designed to induce resistance against residual tumor cells persisting after BMT. Previous stu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kwak LW,Campbell MJ,Zelenetz AD,Levy R

    更新日期:1990-12-01 00:00:00

  • Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell-depleted allogeneic marrow transplantation for chronic myelogenous leukemia.

    abstract::The effect of donor/recipient histocompatibility on relapse in patients receiving T-cell-depleted (TCD) grafts for chronic myelogenous leukemia (CML) was evaluated. Specifically, we sought to determine whether TCD results in an attenuation of the graft-versus-leukemia (GVL) effect on recipients of unrelated marrow gra...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hessner MJ,Endean DJ,Casper JT,Horowitz MM,Keever-Taylor CA,Roth M,Flomenberg N,Drobyski WR

    更新日期:1995-11-15 00:00:00

  • A new transacting factor that modulates hypoxia-induced expression of the erythropoietin gene.

    abstract::Hypoxia is a strong stimulus for the transcription of a set of genes, including erythropoietin and vascular endothelial growth factor. Here we report on the cloning, functional significance, and expression of a complementary DNA (cDNA) that is involved in hypoxia-mediated expression of these 2 genes. The full-length c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gupta M,Mungai PT,Goldwasser E

    更新日期:2000-07-15 00:00:00

  • The principal results of the International Immune Tolerance Study: a randomized dose comparison.

    abstract::The International Immune Tolerance Study was a multicenter, prospective, randomized comparison of high-dose (HD; 200 IU/kg/d) and low-dose (LD; 50 IU/kg 3 times/week) factor VIII regimens in 115 "good-risk," severe high-titer inhibitor hemophilia A subjects. Sixty-six of 115 subjects reached the defined study end poin...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2011-08-369132

    authors: Hay CR,DiMichele DM,International Immune Tolerance Study.

    更新日期:2012-02-09 00:00:00

  • Proteolytic inactivation of ADAMTS13 by thrombin and plasmin.

    abstract::The multimeric size and the function of circulating von Willebrand factor are modulated via its proteolytic cleavage by the plasma metalloproteinase, ADAMTS13. It is unclear how ADAMTS13 activity is regulated within the vascular system. In the absence of a regulatory mechanism, ADAMTS13 activity might compromise plate...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-03-1101

    authors: Crawley JT,Lam JK,Rance JB,Mollica LR,O'Donnell JS,Lane DA

    更新日期:2005-02-01 00:00:00

  • VEGF(165) promotes survival of leukemic cells by Hsp90-mediated induction of Bcl-2 expression and apoptosis inhibition.

    abstract::Similar to endothelial cells (ECs), vascular endothelial growth factor (VEGF) induces Bcl-2 expression on VEGF receptor-positive (VEGFR(+)) primary leukemias and cell lines, promoting survival. We investigated the molecular pathways activated by VEGF on such leukemias, by performing a gene expression analysis of VEGF-...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.7.2532

    authors: Dias S,Shmelkov SV,Lam G,Rafii S

    更新日期:2002-04-01 00:00:00

  • New transgenic evidence for a system of sympathetic axons able to express tissue plasminogen activator (t-PA) within arterial/arteriolar walls.

    abstract::Sympathetic axons embedded in a few arterioles and vasa vasora were recently shown to store tissue plasminogen activator (t-PA) in vesicles. But the extension of such t-PA axons to arteries and arterioles throughout the organism has not been verified. Confirmation of this anatomy would identify a second significant so...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-12-4884

    authors: Hao Z,Guo C,Jiang X,Krueger S,Pietri T,Dufour S,Cone RE,O'Rourke J

    更新日期:2006-07-01 00:00:00

  • Selective expression of CD45 isoforms defines CALLA+ monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cells.

    abstract::The peripheral blood lymphocytes from 42 patients with multiple myeloma (MM) and 13 patients with monoclonal gammopathy of undetermined significance (MGUS) were studied by three-color immunofluorescence (IF) using antibodies directed to a broad range of B-cell markers (CD19, CD20, CD21, CD24), CALLA (CD10), PCA-1 (a p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Jensen GS,Mant MJ,Belch AJ,Berenson JR,Ruether BA,Pilarski LM

    更新日期:1991-08-01 00:00:00

  • Functional mapping of anti-factor IX inhibitors developed in patients with severe hemophilia B.

    abstract::Development of inhibitory antibodies is a serious complication of treatment with repeated factor IX infusions in a minority of patients with hemophilia B. Such antibodies detected in 8 patients have been characterized. Typing studies revealed that patients' immune response toward factor IX is highly heterogeneous and ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.5.1416

    authors: Christophe OD,Lenting PJ,Cherel G,Boon-Spijker M,Lavergne JM,Boertjes R,Briquel ME,de Goede-Bolder A,Goudemand J,Gaillard S,d'Oiron R,Meyer D,Mertens K

    更新日期:2001-09-01 00:00:00

  • A test for Fanconi's anemia.

    abstract::A simple and reliable cytogenetic test for Fanconi's anemia (FA) that is based on the hypersensitivity of FA cells to mitomycin C (MC) is described. Equal volumes of whole blood from a patient in whom the diagnosis of FA is suspected and from a normal person of the opposite sex are co-cultured in phytohemagglutinin-co...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: German J,Schonberg S,Caskie S,Warburton D,Falk C,Ray JH

    更新日期:1987-06-01 00:00:00

  • Effects of parenteral recombinant human macrophage colony-stimulating factor on monocyte number, phenotype, and antitumor cytotoxicity in nonhuman primates.

    abstract::Recombinant human macrophage colony-stimulating factor (rhM-CSF) was given to cynomolgus monkeys by continuous intravenous infusion or subcutaneous injection, at a dose of 50 to 100 micrograms/kg/d in repetitive 14-day cycles. Starting within 24 to 48 hours of initiation of rhM-CSF, there was a progressive increase in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Munn DH,Garnick MB,Cheung NK

    更新日期:1990-05-15 00:00:00

  • A distinct pattern of cytokine gene expression by human CD83+ blood dendritic cells.

    abstract::Dendritic cells are the most potent antigen-presenting cells of the immune system. Although dendritic cells are likely to secrete selective cytokines that facilitate antigen presentation, the difficulty in isolating pure dendritic cells in sufficient numbers has made assessment of this function imprecise. In this stud...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Zhou LJ,Tedder TF

    更新日期:1995-11-01 00:00:00

  • Donor T-cell alloreactivity against host thymic epithelium limits T-cell development after bone marrow transplantation.

    abstract::Acute graft-versus-host disease (aGVHD) impairs thymus-dependent T-cell regeneration in recipients of allogeneic bone marrow transplants through yet to be defined mechanisms. Here, we demonstrate in mice that MHC-mismatched donor T cells home into the thymus of unconditioned recipients. There, activated donor T cells ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-07-034157

    authors: Hauri-Hohl MM,Keller MP,Gill J,Hafen K,Pachlatko E,Boulay T,Peter A,Holländer GA,Krenger W

    更新日期:2007-05-01 00:00:00

  • Antibody to granulocyte-macrophage colony-stimulating factor is a dominant anti-cytokine activity in human IgG preparations.

    abstract::Pharmaceutical preparations of normal human immunoglobulin (IgG) are known to contain high-avidity and neutralizing antibodies (Ab) to the cytokines interleukin (IL)-1alpha, IL-6, and interferon (IFN)alpha. To test for other cytokine Ab, 23 batches of IgG were tested for saturable binding to eight 125I-labeled recombi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Svenson M,Hansen MB,Ross C,Diamant M,Rieneck K,Nielsen H,Bendtzen K

    更新日期:1998-03-15 00:00:00

  • Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells.

    abstract::Endothelial cells play an important role in the regulation of fibrinolysis by the production of several key regulatory proteins. The cytokines tumor necrosis factor (TNF), lymphotoxin, and interleukin-1 (IL-1), but not interleukin-6, increase the production of plasminogen activator inhibitor-1 (PAI-1) by endothelial c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: van Hinsbergh VW,van den Berg EA,Fiers W,Dooijewaard G

    更新日期:1990-05-15 00:00:00

  • Mast cell growth factor (c-kit ligand) supports the growth of human multipotential progenitor cells with a high replating potential.

    abstract::The replating capability of human multipotential (colony-forming unit-granulocyte-erythrocyte-macrophage-megakaryocyte [CFU-GEMM]) and erythroid (burst-forming unit-erythroid [BFU-E]) progenitors was assessed in vitro as a potential measure of self-renewal using purified, recombinant (r) human (hu) or murine (mu) mast...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Carow CE,Hangoc G,Cooper SH,Williams DE,Broxmeyer HE

    更新日期:1991-11-01 00:00:00

  • Role of GM-CSF signaling in cell-based tumor immunization.

    abstract::Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a potent adjuvant in cancer vaccination; however, the specific role of endogenous GM-CSF remains unknown. We performed cell-based vaccination in 2 tumor models. First, we vaccinated C57BL/6 mice lacking either GM-CSF, IL-5, or beta-common chain (betac), a re...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-06-161075

    authors: Zarei S,Schwenter F,Luy P,Aurrand-Lions M,Morel P,Kopf M,Dranoff G,Mach N

    更新日期:2009-06-25 00:00:00

  • Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy.

    abstract::Treatment outcomes for older patients with acute myeloid leukemia (AML) have remained dismal. This randomized, phase 2 trial in AML patients not considered suitable for intensive induction therapy compared low-dose cytarabine (LDAC) with or without volasertib, a highly potent and selective inhibitor of polo-like kinas...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2014-03-560557

    authors: Döhner H,Lübbert M,Fiedler W,Fouillard L,Haaland A,Brandwein JM,Lepretre S,Reman O,Turlure P,Ottmann OG,Müller-Tidow C,Krämer A,Raffoux E,Döhner K,Schlenk RF,Voss F,Taube T,Fritsch H,Maertens J

    更新日期:2014-08-28 00:00:00